Natural polyphenols as prospective inhibitors for MMPs remodeling in human diseases

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

ECM composition and turnover is carefully regulated by various proteases, among which the most important are matrix metalloproteinases (MMPs). Many MMP inhibitors have been followed as clinical applicants for targeting MMPs, but most of these studies have failed during clinical trials due to side effects resulting from broad-spectrum inhibition and inefficiency of inhibitors and regulation of MMPs during diseases is very complicated. Development of MMPs inhibitors from natural products showed beneficial effects in various diseases like cancer, cardiovascular, skin-aging, neurodegenerative diseases, and other. These natural products include secondary metabolites of edible and nonedible plants, such as polyphenols, monophenols, and others. Polyphenols are ample micronutrients in our diet and its beneficial effects depend on the quantity consumed and on their bioavailability. In this chapter, the various types of polyphenols, such as flavonoids, curcuminoids, phenolic acids, etc. and their biological activity to regulate the MMPs in cancer, cardiovascular and other diseases are reviewed.

Cite

CITATION STYLE

APA

Rustagi, Y., Jain, A., Saxena, S., & Rani, V. (2017). Natural polyphenols as prospective inhibitors for MMPs remodeling in human diseases. In Proteases in Human Diseases (pp. 263–283). Springer Singapore. https://doi.org/10.1007/978-981-10-3162-5_13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free